Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds
- 25 January 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 20 (2) , 229-250
Abstract
Importance of the field: The enzyme indoleamine 2,3-dioxygenase (IDO) regulates immune responses through the capacity to degrade the essential amino-acid tryptophan into kynurenine and other downstream metabolites that suppress effector T-cell function and favour the differentiation of regulatory T cells. The current experimental evidence indicates that IDO can be expressed by a variety of cell types, including dendritic cells, tumour cells and stromal cells. Recently, IDO has been implicated in B-cell stimulation and autoantibody production in experimental models of autoimmune diseases.Areas covered in this review: Advances in the biochemistry of IDO and our understanding of the biological relevance of IDO-mediated tryptophan consumption to the establishment of immune tolerance are summarised and discussed. A selection of recent patents in the field are also reviewed and analysed.What the reader will gain: Readers will gain an overview of the patented compounds with IDO inhibitory activity from an immuno...Keywords
This publication has 174 references indexed in Scilit:
- Indoleamine 2,3-dioxygenase overexpression causes kynurenine-modification of proteins, fiber cell apoptosis and cataract formation in the mouse lensLaboratory Investigation, 2009
- Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenaseProceedings of the National Academy of Sciences, 2008
- IDO: A double-edged sword for TH1/TH2 regulationImmunology Letters, 2008
- Structure Based Development of Phenylimidazole-Derived Inhibitors of Indoleamine 2,3-DioxygenaseJournal of Medicinal Chemistry, 2008
- Emerging concepts in CD8+ T regulatory cellsCurrent Opinion in Immunology, 2008
- Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammationProceedings of the National Academy of Sciences, 2008
- Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenaseImmunology Letters, 2008
- Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class INature Immunology, 2008
- Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: Absence of toxicity due to saturating absorptionFood and Chemical Toxicology, 2008
- Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient MiceCell, 1997